Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Definitions: GLP compliance monitoring
3. Definitions: national GLP compliance programme
4. OECD decision-recommendation C(89)87 (final)
5. Revised guidance for good laboratory practice
6. Revised guidance for laboratory inspections
7. GLP compliance recognition in member countries
8. Conditions member parties must comply with
9. Annex III to OECD council decision
10. Main points of annex III (1)
11. Main points of annex III (2)
12. Main points of annex III (3)
13. OECD
14. OECD MAD program
15. Scope of the GLP principles
16. Monitoring authorities I
17. Monitoring authorities II
18. Monitoring authorities III
19. Monitoring authorities IV
20. Main differences
21. 3 levels of authorities
22. Example: the Netherlands
23. GLP compliance monitoring in the Netherlands
24. GLP organisation in Germany
25. USA, medicinal products
26. Korea
27. Japan: 7 programmes
28. Monitoring programme administration
29. Keeping confidentiality
30. Confidentiality
31. Personnel employment and training
32. The inspector
33. Strictly governmental monitoring authorities
34. Outsourced to an accreditation body
35. Partly governmental, partly accreditation bodies
36. (National) GLP compliance programme
37. How to enter a programme
38. Fees

Topics Covered

• Compliance monitoring
• Inspection of companies and laboratories
• Assessing their adherence to the OECD Principles of Good Laboratory Practice

Links

Series:

• Good Laboratory Practice

Categories:

• Methods
• Pharmaceutical Sciences

Talk Citation

Helder, T. (2012, March 12). Compliance monitoring systems and organization around the world [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/UKWY6731.
Export Citation (RIS)

Publication History

• Published on March 12, 2012

Financial Disclosures

• Mr. Theo Helder has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.